UBE2T has been demonstrated to promote the growth of HCC cells by regulating ubiquitination of P53, transition of the G2/M phase of the cell cycle, and the protein kinase B signaling pathway (Liu et al., 2019a; Liu et al., 2017; Wei et al., 2019). This evidence concerns the gene TP53 and hepatocellular carcinoma.